A signaling pathway in cells that regulates fat production could become a new target for cancer drugs, according to Weill Cornell Medicine researchers.
A group led by assistant professor Justin Wilson has developed a binding molecule that could improve targeted alpha-particle therapy - injected radiation treatment - for prostate cancer patients.
Advances in scientific innovation are leading to powerful discoveries about Alzheimer’s and neurodegenerative diseases according to experts at the Appel Alzheimer’s Disease Research Institute Symposium.
